Predictors of sharing injection equipment by HIV-seropositive injection drug users.
about
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersSecondary prevention of HIV infection: the current state of prevention for positivesSecondary prevention of HIV in the United States: past, current, and future perspectives.At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City.Mental health in HIV seronegative and seropositive IDUs in South FloridaSocial network characteristics and HIV sexual risk behavior among urban African American women.Does initiation of HIV antiretroviral therapy influence patterns of syringe lending among injection drug users?Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego.The filter of choice: filtration method preference among injecting drug users.Is injection serosorting occurring among HIV-positive injection drug users? Comparison by injection partner's HIV statusHIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users.Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study.Association of higher-risk alcohol consumption with injecting paraphernalia sharing behaviours in intravenous drug users.
P2860
Q28483820-3AA7E6D6-8400-438B-8988-B38122633A36Q30378147-838E3020-44FC-4D14-AED1-1AA14915FB17Q30499536-9CA90D43-653E-4107-B167-B435A4969B6EQ33705656-7E09F836-3728-4B16-A39F-7AA4F64F44BFQ33751012-E81967A8-28A1-43E7-A1F6-9EC90A38AF71Q34588017-380A2C09-CC33-41BE-BA06-0DBE5EE9E8D4Q34648900-3E891FF4-0417-4156-ACD9-380137CF67B1Q34691743-37552DC8-42A7-43B1-9369-F9334289AF2CQ35222541-B432A26D-D12C-486D-B2FE-0CDFF97B293EQ35597465-DBFFE56A-FEB2-4567-A933-31CB7AF810A4Q35659939-28D676DC-81C3-43DF-976A-1BEA5EC084E9Q36257356-281500A9-2FF2-4978-AB64-3CCD24A4251AQ36919650-B18474DD-F8B6-4671-9A45-F7C40677B0DEQ37430582-6D591784-1D63-427C-82CE-3F78FF8035C1Q50722609-C8666E66-41AB-4653-8433-8102714B3E2C
P2860
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@ast
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@en
type
label
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@ast
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@en
prefLabel
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@ast
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@en
P2093
P2860
P1476
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
@en
P2093
Amy R Knowlton
Amy S Buchanan
Carl A Latkin
Intervention for Seropositive Injectors--Research Evaluation Team
Kelly Knight
Lisa R Metsch
Mary H Latka
Yuko Mizuno
P2860
P304
P356
10.1097/QAI.0B013E31818A6546
P407
P577
2008-12-01T00:00:00Z